Comparative Pharmacology
Head-to-head clinical analysis: CALCITRIOL versus RAYALDEE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CALCITRIOL versus RAYALDEE.
CALCITRIOL vs RAYALDEE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Calcitriol, the active form of vitamin D, binds to vitamin D receptors (VDR) in target tissues, modulating gene transcription. It increases intestinal calcium and phosphate absorption, enhances renal tubular reabsorption of calcium, and promotes bone mineralization by stimulating osteoblast activity.
Rayaldee (calcifediol) is a vitamin D3 analog that is converted to the active hormone calcitriol by 1-alpha-hydroxylase in the kidney. It acts as a vitamin D receptor agonist, increasing intestinal absorption of calcium and phosphate, promoting renal tubular reabsorption of calcium, and suppressing parathyroid hormone (PTH) secretion. In CKD patients, it lowers elevated PTH levels.
0.25-0.5 mcg orally once daily, may increase by 0.25 mcg/day at 4-8 week intervals; maximum 2 mcg/day.
30 mcg orally once daily at bedtime.
None Documented
None Documented
Clinical Note
moderateCalcitriol + Sulfisoxazole
"The metabolism of Sulfisoxazole can be decreased when combined with Calcitriol."
Clinical Note
moderateCalcitriol + Erythromycin
"The metabolism of Erythromycin can be decreased when combined with Calcitriol."
Clinical Note
moderateCalcitriol + Cyclosporine
"The metabolism of Cyclosporine can be decreased when combined with Calcitriol."
Clinical Note
moderateCalcitriol + Fluconazole
5–8 hours (terminal) in normal renal function; prolonged up to 18–24 hours in chronic kidney disease (CKD) due to reduced clearance.
Terminal elimination half-life is approximately 14-19 hours, reflecting the extended-release formulation designed for once-daily dosing.
Renal (fecal after biliary excretion of metabolites): ~10% unchanged in urine; ~70% as metabolites in feces via bile.
Primarily fecal via biliary excretion (70-80%); renal excretion accounts for <10% of total clearance.
Category A/B
Category C
Vitamin D Analog
Vitamin D Analog
"The metabolism of Fluconazole can be decreased when combined with Calcitriol."